Jasper Therapeutics, Inc.

0.50 USD
-0.01 (-1.73%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Jasper Therapeutics, Inc. stock is down -32.27% since 30 days ago. The next earnings date is Mar 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 December’s closed higher than November.

About Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering. The company is based in Redwood City, California.